Malaysia has begun a phase 3 clinical trial of a Covid-19 vaccine developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences.According to reports,the initiative is a collaboration between the governments of Malaysia and China to generate scientific data in the development of the vaccine to evaluate its safety and efficacy against Covid-19. The trials will involve nine government hospitals across Malaysia and 3,000 volunteers for a period of 13 months.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?